BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27130783)

  • 1. Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake.
    Sakai H; Kai Y; Takase K; Sato K; Kimura M; Tabata S; Yaegashi M; Sato F; Yomoto T; Narita M
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):753-9. PubMed ID: 27130783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice.
    Zhou J; Martin RJ; Raggio AM; Shen L; McCutcheon K; Keenan MJ
    Mol Nutr Food Res; 2015 May; 59(5):1000-3. PubMed ID: 25631638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
    Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
    Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: expression of peptide YY, proglucagon, neuropeptide Y receptor Y2, and glucagon-like peptide-1 receptor in bovine peripheral tissues.
    Pezeshki A; Muench GP; Chelikani PK
    J Dairy Sci; 2012 Sep; 95(9):5089-5094. PubMed ID: 22916913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
    Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
    Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 (GLP-1) increases in plasma and colon tissue prior to estrus and circulating levels change with increasing age in reproductively competent Wistar rats.
    Johnson ML; Saffrey MJ; Taylor VJ
    Peptides; 2017 Apr; 90():55-62. PubMed ID: 28237410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
    J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
    Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
    Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.
    Flannery BM; Clark ES; Pestka JJ
    Toxicol Sci; 2012 Dec; 130(2):289-97. PubMed ID: 22903826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.
    Zhou J; Martin RJ; Tulley RT; Raggio AM; McCutcheon KL; Shen L; Danna SC; Tripathy S; Hegsted M; Keenan MJ
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1160-6. PubMed ID: 18796545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine promotes gut hormone release and reduces food intake in rodents.
    Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
    Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
    Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
    Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
    Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
    Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourteen weeks of treatment with Viscofiber increased fasting levels of glucagon-like peptide-1 and peptide-YY.
    Greenway F; O'Neil CE; Stewart L; Rood J; Keenan M; Martin R
    J Med Food; 2007 Dec; 10(4):720-4. PubMed ID: 18158848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.